Navidea Biopharmaceuticals Inc logo

Navidea Biopharmaceuticals Inc

NEW
OTCPK:NAVB (USA)  
$ 0.00 0 (0%) 12:08 AM EST
At Loss
Market Cap:
$ 100.00K
Enterprise V:
$ -2.50M
Volume:
-
Avg Vol (2M):
10.59K
Trade In:
Volume:
-
At Loss
Avg Vol (2M):
10.59K

Business Description

Navidea Biopharmaceuticals Inc logo
Navidea Biopharmaceuticals Inc
NAICS : 325413 SIC : 2835
ISIN : US63937X1037
Description
Navidea Biopharmaceuticals Inc is a biotechnology company specializied in precision medicine. Its products, precision immunodiagnostic agents and immunotherapeutic products are designed to assist in the identification of undetected diseases and to improve targeted treatment. The company's platform, known as Manocept technology, aims to develop next-generation targeted diagnostics and therapies for cancer, autoimmune conditions, and other inflammatory diseases. One of the company's products is Lymphoseek, a radioactive diagnostic agent indicated to locate lymph nodes.

Financial Strength

Name Current Vs Industry Vs History

Growth Rank

Name Current Vs Industry Vs History

Momentum Rank

Name Current Vs Industry Vs History
9-Day RSI 46.78
14-Day RSI 44.99
6-1 Month Momentum % -97.22
12-1 Month Momentum % -98

Liquidity Ratio

Name Current Vs Industry Vs History

Dividend & Buy Back

Name Current Vs Industry Vs History

Profitability Rank

Name Current Vs Industry Vs History
FCF Margin % -990700

GF Value Rank

Name Current Vs Industry Vs History
EV-to-EBIT 0.28
EV-to-EBITDA 0.28
EV-to-Revenue -2505
Earnings Yield (Greenblatt) % 357.14
FCF Yield % -9907

Financials

NAVB's 30-Y Financials
Income Statement Breakdown FY
No Enough Data
Balance Sheet Breakdown
No Enough Data
Cashflow Statement Breakdown
No Enough Data

Historical Operating Revenue by Business Segment

Historical Operating Revenue by Geographic Region

5-Step DuPont Analysis as of
No Enough Data

Guru Trades

See Details
To

Insider Trades

See Details
To

Gurus Latest Trades with OTCPK:NAVB

No Available Data

Peter Lynch Chart

Y-axis scale:
Interactive Chart
To

Performance

Dividend
Log
Bar
To

Annualized Return %  

Symbol
1 Week
1 Month
3 Months
6 Months
YTD
1 Year
3 Years
5 Years
10 Years

Total Annual Return %  

Symbol
2024
2023
2022
2021
2020
2019
2018
2017
2016
2015

Navidea Biopharmaceuticals Inc Executives

Details

GF Value

Valuation Chart

Year:

Analyst Estimate

Key Statistics

Name Value
Revenue (TTM) (Mil $) 0.001
EPS (TTM) ($) -0.06
Beta 1.22
Volatility % 435.35
14-Day RSI 44.99
14-Day ATR ($) 0.002105
20-Day SMA ($) 0.001
12-1 Month Momentum % -98
52-Week Range ($) 0.0001 - 0.13
Shares Outstanding (Mil) 100.08

Piotroski F-Score Details

Year:
Component Result
Piotroski F-Score 0
Positive ROA
Positive CFROA
Higher ROA yoy
CFROA > ROA
Lower Leverage yoy
Higher Current Ratio yoy
Less Shares Outstanding yoy
Higher Gross Margin yoy
Higher Asset Turnover yoy

Navidea Biopharmaceuticals Inc Filings

Filing Date Document Date Form
No Filing Data

Navidea Biopharmaceuticals Inc Stock Events

Financials Calendars
Event Date Price($)
No Event Data

Navidea Biopharmaceuticals Inc Frequently Asked Questions

What is Navidea Biopharmaceuticals Inc(NAVB)'s stock price today?
The current price of NAVB is $0.00. The 52 week high of NAVB is $0.13 and 52 week low is $0.00.
When is next earnings date of Navidea Biopharmaceuticals Inc(NAVB)?
The next earnings date of Navidea Biopharmaceuticals Inc(NAVB) is .
Does Navidea Biopharmaceuticals Inc(NAVB) pay dividends? If so, how much?
Navidea Biopharmaceuticals Inc(NAVB) does not pay dividend.

Press Release

Subject Date
No Press Release

Headlines

See More
  • 1
No news.
  • 1